LAWRENCE LANDRIGAN: Open Payments
NPI 1922194596 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 104 payments from 17 companies in 2025. Trend: 2023 $2,563 · 2024 $2,859 · 2025 $1,970
Food & beverage: $1,970
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $484 |
| PFIZER INC. | 23 | $243 |
| UCB, Inc. | 10 | $233 |
| ABBVIE INC. | 8 | $167 |
| Novartis Pharmaceuticals Corporation | 7 | $166 |
| Lilly USA, LLC | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 4 | $89 |
| Radius Health, Inc. | 4 | $89 |
| Aurinia Pharma U.S., Inc. | 4 | $68 |
| Organon LLC | 3 | $64 |
Products named: OTEZLA, XELJANZ, Bimzelx, COSENTYX, RINVOQ, TALTZ, SAPHNELO, Tymlos.
Industry payments across NC — which companies pay providers there.
